$4.02
N/A
At close: Jul 22, 5:00 PM EST
$4.02
N/A
After Hours: 4:00 PM EST
Oramed Pharmaceuticals Inc Earnings Estimates
ORMPNASDAQ
Oramed Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:ORMP
Oramed Pharmaceuticals (ORMP) is scheduled to report Q2 earnings on August 13, 2026. Analysts estimate EPS of $0.43 and quarterly revenue of N/A.
In the most recent quarter (Q1), Oramed Pharmaceuticals reported EPS of $0.91, beating estimates of $-0.08 by 12.38%. Revenue came in at $0, meeting the estimate of $0 by 0.00%.
Oramed Pharmaceuticals has beaten EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Oramed Pharmaceuticals has averaged an EPS surprise of 10.59% and a revenue surprise of 0.00%.
Earnings Date
Aug 13
EPS Estimate
$0.430
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Oramed Pharmaceuticals Earnings History
Analyze the earnings history of Oramed Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Oramed Pharmaceuticals (ORMP) Earnings Per Share
The chart below shows Oramed Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Oramed Pharmaceuticals (ORMP) Revenue
The chart below shows Oramed Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?
Oramed Pharmaceuticals (ORMP) is scheduled to report earnings on August 13, 2026. The last reported earnings were for reported on May 19, 2026 for Q1.
What were the latest earnings per share (EPS) for Oramed Pharmaceuticals (NASDAQ:ORMP)?
The Actual EPS was $0.91, which beat the estimate of $-0.08.
What were Oramed Pharmaceuticals’s (NASDAQ:ORMP) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
